'Next decade is likely to be a golden era' for ASX shares in this sector

This stock is expected to deliver healthy returns according to a fund manager.

An investment team are very excited about the ASX healthcare share we're going to look at.

The ASX includes businesses from various healthcare sectors, including vaccine makers, private hospital operators, private health insurance providers, and device makers.

Aged care operator Regis Healthcare Ltd (ASX: REG) is one business worthy of attention, according to fund manager Blackwattle's small-cap investment team.

The company provides services to more than 9,000 older Australians through residential aged care homes, home care service hubs, day therapy and respite centres, and retirement villages.

The ASX healthcare share had a strong August, with the Regis share price increasing by 22% over the reporting season month. It reported revenue from services increased 29.9% to $1.01 billion, underlying operating profit (EBITDA) grew 28.7% to $107.2 million, and underlying net profit grew 24.7% to $35.6 million.

While the result was solid, Blackwattle is most excited about the outlook.

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares

Image source: Getty Images

Improved outlook

The fund manager said the rise in the Regis Healthcare share price reflected a "significant change in the outlook for operators in the aged care industry."

Providing care and funding for aged care is a long-term issue for Australia – Blackwattle said governments have historically "kicked the can down the road for the next government to deal with".

Blackwattle then said:

But with the first baby boomers now moving into care the consequence of insufficient investment is upon us. The current government has no choice but to increase the funding of aged care operators to encourage the buildout of more beds. We believe the next decade is likely to be a golden era for aged care operators.

The Regis Healthcare share price jumped another 11% over the two days following the government's announcement that new aged care entrants will make larger means-tested contributions.

Regis is planning for growth

The ASX healthcare share expects to benefit over time from the "ageing population, improved workforce availability, additional government funding and strategic growth initiatives".

It plans to use its balance sheet and debt facility to pursue more acquisitions and greenfield development sites to grow shareholder value.

For example, in December 2023, it completed the acquisition of CPSM, which included five residential aged care homes in southeast Queensland with 644 beds for $75.2 million. The homes had an average occupancy of 97% in FY24.

The company also has a number of planned greenfield sites. The 112-bed Camberwell (VIC) site is in development, while the 123-bed Toowong (QLD) site is due to commence construction soon.

Future greenfield development locations include the 99-bed Belrose (NSW) and 101-bed Carlingford (NSW) sites, with development approval in place for both projects.

Overall, the ASX healthcare share believes there is insufficient new supply coming onto the market to meet the expected demand, which could push occupancy higher.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientists working in the laboratory and examining results.
Healthcare Shares

Neuren Pharmaceuticals shares just hit a 12-month high. There could be more good news to come

This week's sales figures were impressive.

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

Do I still rate CSL shares as a buy after rising 120% in four months?

Let's see if it is too late to buy this biotech giant's shares.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Healthcare Shares

CSL shares push past $200: Is $250 next?

How much further can the CSL share price rally go?

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

ResMed or Cochlear: Which ASX healthcare share would I buy today?

I like both businesses for the long term, but their recent financial performances have given me something to think about.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Could Telix Pharmaceuticals shares double in value over the next 12 months?

Find out if the ASX biotech stock is a buy, sell, or hold now.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

3 compelling reasons to consider buying Mesoblast shares

This company has a lot going on, plus strong revenues.

Read more »

Doctor with stethoscope typing on her computer.
Healthcare Shares

Are CSL shares a buy, hold, or sell at their 52-week high?

Investors have become much more optimistic about its future. But has the share price recovery gone too far?

Read more »

Senior man looking at his laptop and pondering something.
Healthcare Shares

Would I buy ResMed shares after today's results?

The company has reported solid revenue and earnings growth. Here's what I make of its performance and current valuation.

Read more »